Almirall's Q3: Soaring Shares, Ebglyss Potential

episode

Business News Today | 2 Min News | The Daily News Now! not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Business News Today | 2 Min News | The Daily News Now!

Japanese Capsule Hotels: Budget Solution for London Hybrid Workers 1 min · 20 Dec 2025

Russia's War Economy: Sustainable or Unsustainable? 2 min · 20 Dec 2025

All episodes from Business News Today | 2 Min News | The Daily News Now! →

Report any issue

Source

Recorded10 Nov 2025

Publisherfeeds.acast.com ↗

Handlerec:2199051

Show notes

Almiralls Q3 financial results exceed expectations, boosting shares by over 8%. EBIT of €67.4M, net income of €39.1M, and total revenue of €825.6M drive the positive performance. Key products like Ebglyss and Ilumetri contribute significantly, while Klisyri falls short. Almirall reaffirms 2025 outlook, projecting net sales growth of 10-13% and EBITDA of €220-240M. Jefferies analysts maintain a Buy rating, citing Ebglyss potential as a preferred first-line treatment in Europe.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.